Pluri Announces August 2026 Equity Financing Transaction
TipRanks (Fri, 28-Aug 8:29 AM ET)
Globe Newswire (Thu, 27-Aug 8:00 AM ET)
Globe Newswire (Mon, 17-Aug 9:00 AM ET)
Ever After Foods Acquires Fishway to Expand Integrated Food Production Technology Platform
Globe Newswire (Mon, 17-Aug 8:30 AM ET)
Globe Newswire (Tue, 28-Jul 8:00 AM ET)
Globe Newswire (Tue, 14-Jul 7:00 AM ET)
Globe Newswire (Tue, 2-Jun 7:30 AM ET)
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Pluri trades on the NASDAQ stock market under the symbol PLUR.
As of September 1, 2026, PLUR stock price declined to $1.46 with 3,569 million shares trading.
PLUR has a beta of 0.45, meaning it tends to be less sensitive to market movements. PLUR has a correlation of 0.01 to the broad based SPY ETF.
PLUR has a market cap of $17.50 million. This is considered a Sub-Micro Cap stock.
Last quarter Pluri reported $167,000 in Revenue and -$.55 earnings per share. This fell short of revenue expectation by $-488,000 and exceeded earnings estimates by $.11.
In the last 3 years, PLUR traded as high as $8.48 and as low as $1.41.
PLUR has underperformed the market in the last year with a price return of -72.3% while the SPY ETF gained +19.3%. PLUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.1% and -8.7%, respectively, while the SPY returned +1.0% and -1.4%, respectively.
PLUR support price is $1.37 and resistance is $1.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLUR shares will trade within this expected range on the day.